India Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Diabetes Care Devices Market, India, Revenue ($m), 2015-2025
3.2 Diabetes Care Devices Market, India, Revenue Mix ($m), 2019
3.3 Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2019
3.4 Diabetes Care Devices Market, India, Revenue ($m), 2015-2025
3.5 Diabetes Care Devices Market, India, Volume (Units), 2015-2025
3.6 Diabetes Care Devices Market, India, Volume (Units), 2015-2025
3.7 Diabetes Care Devices Market, India, Company Share by Revenue ($m), 2019

4.1 Glucose Monitoring Market, India, Revenue ($m), 2015-2025
4.1.1 Blood Glucose Meters Market, India, Revenue ($m), by Segment, 2015-2025
4.2 Glucose Monitoring Market, India, Volume (Units), 2015-2025
4.2.1 Blood Glucose Meters Market, India, Volume (Units), by Segment, 2015-2025
4.3 Glucose Monitoring Market, India, Average Price ($), 2015-2025
4.4 Glucose Monitoring Market, India, Distribution Share by Revenue ($m), 2019
4.5 Glucose Monitoring Market, India, Company Share by Revenue ($m), 2019

5.1 Insulin Delivery Market, India, Revenue Mix ($m), 2019
5.2 Insulin Delivery Market, India, Segment Contribution (%), 2019
5.3 Insulin Delivery Market, India, Revenue ($m), 2015-2025
5.3.1 Insulin Pens Market, India, Revenue ($m), by Segment, 2015-2025
5.3.2 Insulin Pumps Market, India, Revenue ($m), by Segment, 2015-2025
5.4 Insulin Delivery Market, India, Volume (Units), 2015-2025
5.4.1 Insulin Pens Market, India, Volume (Units), by Segment, 2015-2025
5.4.2 Insulin Pumps Market, India, Volume (Units), by Segment, 2015-2025
5.5 Insulin Delivery Market, India, Average Price ($), 2015-2025
5.6 Insulin Delivery Market, India, Distribution Share by Revenue ($m), 2019
5.7 Insulin Delivery Market, India, Company Share by Revenue ($m), 2019

6.1 DexCom Inc
6.1.1 Company Overview
6.2 Novo Nordisk AS
6.2.1 Company Overview
6.3 Medtronic Plc
6.3.1 Company Overview
6.4 Abbott Laboratories
6.4.1 Company Overview
6.5 Sanofi
6.5.1 Company Overview
6.6 Eli Lilly and Co
6.6.1 Company Overview
6.7 F. Hoffmann-La Roche Ltd
6.7.1 Company Overview
6.8 Insulet Corp
6.8.1 Company Overview

8.1 Debt Offerings
8.1.1 Piramal Enterprises Raises USD99.5 Milion in Private Placement of 10.25% Debentures Due 2021
8.1.2 Piramal Enterprises to Raise up to USD247 Million in Private Placement of Convertible Debentures
8.2 Equity Offerings
8.2.1 Piramal Enterprises Raises USD515.7 Million in Rights Offering of Shares

9.1 Corporate Communications
9.1.1 Dec 03, 2019: Siddharth Mittal takes over as CEO and Joint Managing Director of Biocon
9.2 Financial Announcements
9.2.1 Feb 04, 2020: Piramal Enterprises announces consolidated results for Q3 & 9M FY2020 ended December 31, 2019
9.2.2 Oct 23, 2019: Biocon Q2FY20 earnings revenue at Rs 1,611 Cr, Up 17 %; EBITDA at Rs 441 Cr, Up 12%; Net Profit (excluding exceptional item) at Rs 189 Cr, Up 3%
9.2.3 Oct 21, 2019: Piramal Enterprises announces consolidated results for the second quarter & half year ended September 30, 2019
9.2.4 Oct 16, 2019: Abbott reports third-quarter 2019 results
9.2.5 Jul 30, 2019: Piramal Enterprises announces consolidated results for the quarter ended June 30, 2019
9.2.6 Jul 25, 2019: Biocon Q1FY 20 revenue rs 1,490Cr, up 25%; EBITDA up 51% at rs 462Cr
9.2.7 Apr 25, 2019: Biocon Q4FY19 Revenue Rs 1,557 Cr, Up 26%; EBITDA Up 43% at Rs 431 Cr; Net Profit Up 64% at Rs 214 Cr
9.3 Legal And Regulatory
9.3.1 Feb 27, 2020: Biocon's small molecules API manufacturing facility completes post - approval and GMP U.S. FDA inspection
9.3.2 Feb 22, 2020: Biocon's insulin manufacturing facility in Malaysia completes U.S. FDA (PAI) inspection
9.3.3 Jan 20, 2020: Biocon's oral solid dosage manufacturing facility completes pre-approval U.S. FDA inspection with zero observations
9.3.4 Nov 05, 2019: Biocon’s Biologics Drug Products facility in Bengaluru receives EIR from U.S. FDA
9.3.5 Sep 20, 2019: U.S. FDA completes pre-approval inspection of two new Biocon Biologics facilities in Bengaluru
9.3.6 Jul 08, 2019: Pre -Approval U.S. FDA Inspection Conducted at Biocon's Insulins Facilities in Malaysia
9.3.7 Jul 08, 2019: Biocon provides update on FDA inspection of its insulin facilities in Malaysia
9.3.8 Jun 14, 2019: Biocon Biologics facilities In Bengaluru receive EU GMP Certification
9.4 Other Significant Developments
9.4.1 Dec 12, 2019: HemoCue, the pioneer and global leader in Hemoglobin point-of-care testing to further strengthen National Activities in the Combat against Anemia in India
9.4.2 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI
9.4.3 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 Consulting
10.3 Contact
10.4 Disclaimer

Table 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2015-2025
Table 2: Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2019
Table 3: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: Diabetes Care Devices Market, India, Volume (Units), 2015-2025
Table 6: Diabetes Care Devices Market, India, Volume (Units), Historic, 2015-2020
Table 7: Diabetes Care Devices Market, India, Volume (Units), Forecast, 2021-2025
Table 8: Diabetes Care Devices Market, India, Company Share by Revenue ($m), USD Constant, 2019
Table 9: Glucose Monitoring Market, India, Revenue ($m), USD Constant, 2015-2020
Table 10: Glucose Monitoring Market, India, Revenue ($m), USD Constant, 2021-2025
Table 11: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, 2015-2020
Table 12: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, 2021-2025
Table 13: Glucose Monitoring Market, India, Volume (Units), 2015-2020
Table 14: Glucose Monitoring Market, India, Volume (Units), 2021-2025
Table 15: Blood Glucose Meters Market, India, Volume (Units), 2015-2020
Table 16: Blood Glucose Meters Market, India, Volume (Units), 2021-2025
Table 17: Glucose Monitoring Market, India, Average Price ($), 2015-2020
Table 18: Glucose Monitoring Market, India, Average Price ($), 2021-2025
Table 19: Glucose Monitoring Market, India, Distribution Share by Revenue ($m), USD Constant, 2019
Table 20: Glucose Monitoring Market, India, Company Share by Revenue ($m), USD Constant, 2019
Table 21: Insulin Delivery Market, India, Segment Contribution (%), 2019
Table 22: Insulin Delivery Market, India, Revenue ($m), USD Constant, 2015-2020
Table 23: Insulin Delivery Market, India, Revenue ($m), USD Constant, 2021-2025
Table 24: Insulin Pens Market, India, Revenue ($m), USD Constant, 2015-2020
Table 25: Insulin Pens Market, India, Revenue ($m), USD Constant, 2021-2025
Table 26: Insulin Pumps Market, India, Revenue ($m), USD Constant, 2015-2020
Table 27: Insulin Pumps Market, India, Revenue ($m), USD Constant, 2021-2025
Table 28: Insulin Delivery Market, India, Volume (Units), 2015-2020
Table 29: Insulin Delivery Market, India, Volume (Units), 2021-2025
Table 30: Insulin Pens Market, India, Volume (Units), 2015-2020
Table 31: Insulin Pens Market, India, Volume (Units), 2021-2025
Table 32: Insulin Pumps Market, India, Volume (Units), 2015-2020
Table 33: Insulin Pumps Market, India, Volume (Units), 2021-2025
Table 34: Insulin Delivery Market, India, Average Price ($), 2015-2020
Table 35: Insulin Delivery Market, India, Average Price ($), 2021-2025
Table 36: Insulin Delivery Market, India, Distribution Share by Revenue ($m), USD Constant, 2019
Table 37: Insulin Delivery Market, India, Company Share by Revenue ($m), USD Constant, 2019
Table 38: Diabetes Care Devices Market Pipeline Products
Table 39: Piramal Enterprises Raises USD99.5 Milion in Private Placement of 10.25% Debentures Due 2021
Table 40: Piramal Enterprises to Raise up to USD247 Million in Private Placement of Convertible Debentures
Table 41: Piramal Enterprises Raises USD515.7 Million in Rights Offering of Shares

Figure 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 2: Diabetes Care Devices Market, India, Revenue Mix ($m), 2019
Figure 3: Diabetes Care Devices Market, India, Category Contribution (%), 2019
Figure 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: Diabetes Care Devices Market, India, Volume (Units), 2015-2025
Figure 6: Diabetes Care Devices Market, India, Volume (Units), Historic, 2015-2025
Figure 7: Diabetes Care Devices Market, India, Company Share (%) 2019
Figure 8: Glucose Monitoring Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 9: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 10: Glucose Monitoring Market, India, Volume (Units), 2015-2025
Figure 11: Blood Glucose Meters Market, India, Volume (Units), 2015-2025
Figure 12: Glucose Monitoring Market, India, Company Share (%) 2019
Figure 13: Insulin Delivery Market, India, Revenue Mix ($m), 2019
Figure 14: Insulin Delivery Market, India, Segment Contribution (%), 2019
Figure 15: Insulin Delivery Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 16: Insulin Pens Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 17: Insulin Pumps Market, India, Revenue ($m), USD Constant, 2015-2025
Figure 18: Insulin Delivery Market, India, Volume (Units), 2015-2025
Figure 19: Insulin Pens Market, India, Volume (Units), 2015-2025
Figure 20: Insulin Pumps Market, India, Volume (Units), 2015-2025
Figure 21: Insulin Delivery Market, India, Company Share (%) 2019 48